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The K526R substitution in viral protein
PB2 enhances the effects of E627K
on inﬂuenza virus replication
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Host-adaptive strategies, such as the E627K substitution in the PB2 protein, are critical for
replication of avian inﬂuenza A viruses in mammalian hosts. Here we show that mutation
PB2-K526R is present in some human H7N9 inﬂuenza isolates, in nearly 80% of H5N1
human isolates from Indonesia and, in conjunction with E627K, in almost all seasonal H3N2
viruses since 1970. Polymerase complexes containing PB2-526R derived from H7N9, H5N1 or
H3N2 viruses exhibit increased polymerase activity. PB2-526R also enhances viral
transcription and replication in cells. In comparison with viruses carrying 627K, H7N9 viruses
carrying both 526R and 627K replicate more efﬁciently in mammalian (but not avian) cells
and in mouse lung tissues, and cause greater body weight loss and mortality in infected mice.
PB2-K526R interacts with nuclear export protein and our results suggest that it contributes
to enhance replication for certain inﬂuenza virus subtypes, particularly in combination
with 627K.
DOI: 10.1038/ncomms6509 OPEN
1 State Key Laboratory for Emerging Infectious Diseases, Department of Microbiology, and the Research Center of Infection and Immunology, The University
of Hong Kong, Hong Kong SAR, China. 2 The Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University,
Hangzhou 310003, China. 3 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou 310003, China.
* These authors contributed equally to this work. Correspondence and requests for materials should be addressed to H.C. (email: hlchen@hku.hk)
or to K.-Y.Y. (email: kyyuen@hku.hk).
NATURE COMMUNICATIONS | 5:5509 | DOI: 10.1038/ncomms6509 |www.nature.com/naturecommunications 1
& 2014 Macmillan Publishers Limited. All rights reserved.
I
nﬂuenza viruses utilize the viral polymerase complex, which is
composed of PB1, PB2 and PA subunits, to replicate and
transcribe the viral genome in the cell nucleus. Adaptation of
viral polymerase is critical for efﬁcient virus replication in a new
host following cross-species transmission1. Several adaptation
markers in the polymerase have been identiﬁed among seasonal
inﬂuenza viruses that are circulating in humans and avian
inﬂuenza viruses, which cause sporadic human infections1,2. The
most well-characterized adaptation marker is PB2 E627K, which
was found in a signiﬁcant proportion of H5N1 human infections
and also in one case of H7N7 infection3,4. However, 627K is not
exclusive to all inﬂuenza viruses that can replicate in humans5,6.
Another adaption marker, PB2 590S/591R, was reported to enable
replication ﬁtness of swine origin 2009 H1N1 virus in humans7,8.
PB2 D701N and Q591K substitutions were also found to support
H5N1 virus replication in mammalian hosts8,9. The E627K
substitution enhances H5N1 virus replication in the upper
respiratory tract, where the temperature, at 33 C, is slightly
lower than the core body temperature8. PB2 627K and 627E/
701N have been associated with enhanced transmission of
inﬂuenza virus in mammalian hosts10. A T271A substitution
in PB2 was also described to enhance replication of 2009 H1N1
and H5N1 viruses in mammalian cells in vitro11–13. PB2 has
been reported to interact with host a-importins; it is thought
that differential binding of PB2 with importin-a1 and -a7 may
regulate inﬂuenza virus polymerase activity14,15. Details of how
these genetic substitutions translate into adaptive mechanisms
remain largely unknown.
While about 50% of H5N1 human isolates contain known PB2
adaptation markers, mainly E627K with some D701N and a few
instances of 591K, as described above, the other half of human
infections are not associated with known adaptation markers16–18.
Indonesia has experienced the highest number of human H5N1
infections, with 195 cases, 163 of which were fatal (http://
www.who.int/inﬂuenza/human_animal_interface/EN_GIP_2014
0124CumulativeNumberH5N1cases.pdf). However, the majority
(80%) of the H5N1 isolates from human cases in Indonesia do not
harbour the PB2 627K or 701N markers. Apart from the markers
described above, inﬂuenza viruses probably utilize uncharacterized
adaptive substitutions in the PB2 polymerase subunit to support
virus replication in human cells. In the spring of 2013, a novel
avian H7N9 virus emerged that crossed the species barrier to
infect humans in eastern China19,20. More than 300 laboratory-
conﬁrmed cases of human infection, about 30% of which were
fatal, have been identiﬁed since March 2013. While sporadic
human infections caused by avian H5N1, H9N2 and H7N7 viruses
have been recorded since 1997 (refs 21–23), no avian inﬂuenza
virus has caused an outbreak of this magnitude since the 1918
pandemic24. It is important to understand how this H7N9 virus
gained the ability to infect humans so easily. Genetic
characterization revealed that the H7N9 virus is a reassortant
virus, possibly generated through multiple reassortment events to
incorporate the haemagglutinin (HA) gene from an H7N3 virus,
the neuraminidase gene originating from an H7N9 virus
circulating in wild birds and other internal genes from H9N2
virus present in poultry19,20,25. Genetic and structural analyses
found that the HA of H7N9 contains a Q226L substitution, which
may confer a certain level of ability for binding to human type
sialic acid receptors26,27. However, the Q226L mutation has been
found in avian H9N2 viruses, which have been prevalent in
poultry for several years, with only a limited number of human
infections having been identiﬁed since 1997 (ref. 28). There is
strong interest in understanding what other features of 2013
H7N9 virus facilitate its infection of humans.
This study analyzes inﬂuenza sequences available from public
databases and also those arising from our analysis of H7N9
isolates from human cases to identify new adaptation marker(s)
in the PB2 gene. Various PB2 adaptation markers are identiﬁed
among the H7N9 human isolates, and a K526R substitution
associated with other previously deﬁned adaptive markers is
detected in some human isolates. Further characterization of the
PB2-526R genotype reveals that H7N9 virus carrying this marker
replicates to a signiﬁcantly higher titre in mammalian cells, and
also in mice. Furthermore, we show that nearly 80% of H5N1
human isolates from Indonesia and almost all seasonal H3N2
inﬂuenza A viruses isolated since 1970 contain PB2-526R.
Reverse mutation of 526R to 526K attenuates polymerase activity
in H3N2 and Indonesia-subclade H5N1 viruses. Therefore, in
addition to 627K, 701N, 590S/591R and 591K, 526R is another
marker of mammalian adaption by avian inﬂuenza viruses,
possibly functioning through interaction between viral PB2 and
nuclear export protein (NEP) during virus replication.
Results
PB2-K526R is present in three inﬂuenza virus subtypes.
Examination of the sequences of H7N9 human isolates has
revealed a variety of different mammalian adaptation markers
present in PB2 genes19,20,29,30. Besides the previously described
627K, 701N and 591K loci19,29,30, we found a K526R genotype
associated with either 627E/627K or 701D/701N (Supplementary
Fig. 1). Subsequent analysis found three distinct major PB2
genotypes, 526R/627K, 526R/701N and 526R alone, to be present
within some isolates obtained from our own study and in some
reported H7N9 human cases identiﬁed since March 2013 in
China (Table 1)20,31,32. The 526R substitution has not previously
been described to be a mammalian adaptation marker for avian
inﬂuenza viruses. However, screening of sequences in the
GenBank inﬂuenza database revealed that K526R is present in
some H5N1 human isolates, particularly those from human cases
in Indonesia (Table 1). This may explain why the majority of
human isolates from Indonesia do not carry the PB2-627K
marker that is commonly found among human infections in
other H5N1-affected areas. Furthermore, sequence analysis found
that the H3N2 virus obtained K526R around 1970 and that the
PB2-526R genotype immediately became the dominant
circulating H3N2 in humans (Fig. 1; Table 1), which has
continued to this day. Since H3N2 virus has been associated
with humans for nearly 50 years, it seems that 526R may be a
previously unidentiﬁed adaptation marker of the polymerase
complex of inﬂuenza virus with the potential to become
established in a viral strain, and may act alone, or in
coordination with other markers, to facilitate viral replication in
humans.
PB2-526R enhances polymerase activity alone and with 672K.
The inﬂuenza A virus viral polymerase complex, which is com-
posed of PB1, PB2 and PA subunits, is used to replicate and
transcribe the viral genome in the cell nucleus. We tested whether
the presence of 526R, either alone or in combination with other
adaptation markers, altered the ribonucleoprotein (RNP) com-
plex polymerase activity of H7N9 virus. We ﬁrst compared
polymerase activity using a minigenome assay, testing all PB2
genotypes identiﬁed from H7N9 viruses for which sequence data
had been publicly released or obtained from our analyses
(Table 1). As expected, PB2 carrying 627K or 701N substitutions
exhibited higher polymerase activity than PB2 derived from an
avian type virus at both 33 and 37 C in human embryonic kidney
293T (HEK293T) cells (Fig. 2a)33,34. Polymerase activity of the
PB2 genotype with 526R was 10-fold higher than that of the
avian-PB2 genotype, while two genotypes of PB2 carrying either
526R/627K or 526R/701N showed moderately increased and also
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consistently higher (two- to ﬁvefold greater) polymerase activity
than that associated with the single PB2 substitutions 627K or
701N. Notably, the enhanced effect of 526R in combination with
627K is consistently more apparent at 33 C (Fig. 2a); this
temperature is believed to favour the replication of inﬂuenza virus
in the upper respiratory tract8. Because the minigenome system
reporter assay mimics virus RNP in cells, any effect may be
reﬂected in levels of viral messenger RNA (mRNA), viral RNA
(vRNA) or protein. To understand whether the change in
polymerase activity is related to differences in the levels of PB2
protein, we analysed viral proteins and found PB2 protein levels
to be lower in the avian-PB2 group, but that there was no
apparent difference between PB2-526R, PB2-701N, 526R/701N,
PB2-627K and PB2-526R/627K in the minigenome assay
(Fig. 2a). However, expression of FLAG-tagged versions of PB2
in the pCMV (cytomegalovirus) vector, which is not affected by
PB2 polymerase properties, showed that avian PB2 has similar
levels of PB2 protein. Hence, lower levels of PB2 protein in RNP
containing avian PB2 are due to the low transcription and
replication efﬁciency associated with avian PB2 and RNP
polymerase complexes, as shown in subsequent experiments
(Fig. 3a,b). In contrast to the result in HEK293T cells, the
polymerase activity associated with avian type PB2 was not
inhibited when avian cells (DF-1) were used in the RNP
polymerase assay (Fig. 2e).
The seasonal H3N2 virus has been circulating continuously in
humans since 1968, and is believed to have gained most of its
adaptations through interaction with its human host. Since the
526R genotype was found among H3N2 viruses from around
1970 onwards and has become prevalent since then, we tested
whether gaining 526R enhanced virus replication. Introduction of
526R into the PB2 of an H3N2 strain pre-dating this change
(A/Hong Kong/1/68) signiﬁcantly increased polymerase activity,
which is consistent with the observations for H7N9 PB2 (Fig. 2b).
Consistent with the effect of introduction of 526R into the 1968
H3N2 PB2 gene, reverse mutation of 526R to 526K in the PB2 of
a recent H3N2 isolate (A/Guangdong/ST798/2008) led to
decreased polymerase activity (Fig. 2c). We postulated that
K526R may have provided additional optimization for the
replication of the H3N2 virus following the incorporation of an
avian PB1 into H2N2 in 1968 (ref. 35). To test this idea, we
analysed the polymerase activity when 526R PB2 was combined
with PB1 from the SG57 (A/Singapore/1/57, H2N2; original PB1)
and Aichi68 (A/Aichi/2/68, H3N2; new avian-source PB1) viruses
using a minigenome backbone derived from the 1957 virus.
We found that replacement of PB1 in the SG57 RNP complex
with A/Puerto Rico/8/1934 (PR8) PB1 resulted in decreased
polymerase activity in repeated assays, suggesting introduction of
PB1 requires compatibility with other subunits in the H2N2 RNP.
However, incorporation of PB1 from Aichi68-H3N2 into the
SG57 backbone, which mimics the formation of the H3N2 RNP
as it occurred in 1968, does not compromise RNP polymerase
activity. Introduction of 526R into the SG57-PB2 (627K)
backbone enhanced polymerase activity. Furthermore, the RNP
containing Aichi68-PB1 and 526R/627K PB2 consistently exerts
higher polymerase activity than either whole SG57 or SG57 with
Aichi68-PB1 in repeated experiments (Supplementary Fig. 2).
Further studies are needed to unveil the role of PB2-526R in
compatibility with PB1. Since 526R is predominantly present
among H5N1 human isolates from Indonesia, we examined the
effect of PB2-526R on polymerase activity in this subclade of the
H5N1 subtype. It is notable that altering 526R to 526K in the PB2
completely abolishes RNP polymerase activity in the minigenome
assay for RNP derived from A/Indonesia/5/2005 (Fig. 2d). These
results clearly show that 526R, alone or coupled with 627K,
provide an adaptive advantage to the polymerase complexes of
avian H7N9 and H5N1 inﬂuenza A viruses during mammalian
cell infection and optimizes RNP ﬁtness during H3N2 virus
replication.
PB2-526R augments viral genome transcription and replica-
tion. To further understand whether the altered RNP polymerase
activity and viral growth associated with 526R versions of PB2 is
due to differences in the efﬁciency of virus genome transcription
and replication, we examined levels of viral mRNA and vRNA in
A549 cells infected with viruses containing different versions of
PB2 at 6 h post infection. Quantitative reverse transcription-PCR
(RT-PCR) analysis with mRNA- or vRNA-speciﬁc primers
showed that A549 cells infected with viruses carrying either 627K,
701N or 526R PB2 have signiﬁcantly higher levels of viral matrix
protein (M1) and nucleoprotein (NP) mRNA and vRNA, as
compared with cells infected with a virus containing avian PB2
(Fig. 3), suggesting these adaptation markers are critical for viral
RNP transcription and replication in mammalian cells during the
early phase of infection. Furthermore, addition of 526R to 627K
or 701N provides an extra advantage in viral RNP transcription
and replication efﬁciency. While the additional enhancement
effect of 526R on 627K or 701N is not as strong as that seen when
627K is introduced into the avian PB2 genotype, the experiments
Table 1 | PB2 proposed mammalian adaptation markers among human and avian H5N1, H9N2, H7N9 and seasonal H3N2
isolates*.
PB2 genotype All H5N1 Indonesia H5N1 H9N2 H7N9 H3N2w
Humanz
(n¼ 261)
Aviany
(n¼ 1,290)
Human
(n¼ 70)
Avian
(n¼48)
Human||
(n¼8)
Avianz
(n¼620)
Human#
(n¼96)
Avian
(n¼47)
1968–71
(n¼90)
1972–2014
(n¼4,872)
Proposed human
adaptation marker
526R 47 194
(74%)
20 342
(27%)
47 56
(80%)
13 13
(27%)
1 7
(88%)
9 207
(33%)
4 81
(84%)
0 3
(6%)
0 90
(100%)
8 4,858
(99.7%)
590S 8 38 0 0 5 192 1 0 0 0
591K 3 0 2 0 0 2 5 0 0 0
627K 114 279 1 0 0 4 61 3 66 17
701N 14 2 0 0 1 0 8 0 0 2
526R/
627K
8 3 6 0 0 0 2 0 24 4,831
Avian genotype** 67 (26%) 948 (73%) 14 (20%) 35 (73%) 1 (12%) 413 (67%) 15 (16%) 44 (94%) 0 14 (0.3%)
*Full-length PB2 sequences of seasonal H3N2, human and avian H5N1, H9N2 and H7N9 inﬂuenza A viruses from NCBI Inﬂuenza Virus Resource Database, and human HPAI H5N1 from Inﬂuenza
Sequence Database were analysed. Right column under each Human/Avian represents total number and percentage of isolates containing adaptation marker.
wFive human H3N2 isolates contains 526R/590S and one has 591K/701N.
zTwo human H5N1 isolates from Indonesia contain 526R/591K; two contain 590S/627K; two are 590S/701N and one contains both 627K and 701N markers.
yTwo avian H5N1 isolates have 627K/701N and ﬁve contain 590S/627K.
||One human H9N2 isolate has triple adaptation markers, 526R/590S/701N.
zThree avian H9N2 isolates contain dual 590S/591K signatures and one has 590S/627K.
#Three human H7N9 isolates contain 526R/701N genotypes.
**Avian genotype indicates isolates that lack any proposed human adaptation markers in the PB2.
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were repeated four times, and consistently demonstrated that
526R exerts a positive effect on virus replication and transcrip-
tion, either alone or when combined with 627K or 701N. It
appears that the effect of 526R on viral genome transcription and
replication is more apparent in the early hours of infection
(Supplementary Fig. 3). These results suggest that 526R enhances
the effects of 627K and 701N adaptations, resulting in optimal
transcription and replication of inﬂuenza virus RNP in mam-
malian cells.
526R synergizes with other PB2 markers in H7N9 replication.
To further characterize the phenotype of viruses carrying 526R
PB2, reverse genetic (RG) versions of viruses from human isolates
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Figure 1 | Phylogenetic tree of H3N2 virus PB2. The PB2 tree was constructed using the neighbour-joining method with the Poisson model of amino-acid
substitution; the reliability of the phylogenetic tree was determined by bootstrap analysis using 1,000 replicates. All sequences were obtained from
Genbank. Viruses in red represent vaccine strains recommended by the World Health Organization.
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carrying the 627K, 701N, 526R/627K, 526R/701N and solely 526R
PB2 genotypes were constructed in the A/Zhejiang/DTID-ZJU01/
2013 backbone. Comparison of the growth kinetics of these
viruses with a similarly constructed RG version of an avian H7N9
strain (A/Chicken/Zhejiang/DTID-ZJU01/2013) revealed that
viruses carrying any of the adaptation markers, including the
novel 526R, replicated to a 1–2 log higher titre than the avian
H7N9 virus in Madin-Darby canine kidney (MDCK) cells
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Figure 2 | Polymerase activity of H7N9 PB2 variants in vitro. (a) HEK293T cells were transfected with H7N9 RNP complexes composed of NP, PB1 and
PA from the A/Zhejiang/DTID-ZJU01/2013 strain and PB2 from different strains containing different adaptation markers, as shown in Table 1, together with
the ﬁreﬂy luciferase reporter pYH-Luci and a Renilla luciferase reporter (internal control). Luciferase activity was measured at 24 h post transfection,
following incubation at 33 or 37 C. Comparison of RNP polymerase activity with PB2 derived from human and avian H7N9 isolates; PB2 protein levels
estimated by western blot for the minigenome assay and FLAG-tagged pCMV clones are shown at the bottom. (b) Comparison of RNP polymerase activity
for H3N2 (A/Hong Kong/1/68) RNP containing PB2 with or without the 526R substitution in HEK293T cells at 24 h post transfection. (c) Comparison
of RNP activity of H3N2 (A/Guangdong/ST798/2008) RNP containing PB2 with or without the 526K reverse mutation in HEK293T cells at 24 h post
transfection. (d) Comparison of RNP activity with H5N1 (A/Indonesia/5/2005) RNP containing PB2-526R or PB2-526K reverse mutation in HEK293Tcells
at 24 h post transfection. (e) DF-1 cells were transfected with the same set of RNP complexes as in a. Luciferase activity was measured at 24 h post
transfection, following incubation at 39 C. Data represent mean luciferase activity from three separate experiments, calculated after normalization
with Renilla luciferase activity,±s.d. ‘—’ represents blank control; RNP without the PB2 gene. Statistical signiﬁcance was analysed by one-way analysis
of variance, corrected by the Bonferroni post-test: ***Po0.001, **Po0.01 and *Po0.05. Full-size uncropped western blots showing PB2 protein levels
are displayed in Supplementary Fig. 6.
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(Fig. 4a). Our results showed that 526R signiﬁcantly enhances
replication of 627K virus at 24 h post infection, but that the
enhancement is less apparent at the 48- and 72-h time points.
One explanation may be that 526R is more critical during the
early phase of virus replication in mammalian cells. Addition of
526R also signiﬁcantly enhanced the growth rate of 701N virus.
To further conﬁrm the role of 526R in virus replication in other
mammalian cells, we tested the same set of RG versions of H7N9
viruses in HEK293T and A549 cells, which are also commonly
used for studying inﬂuenza virus infection. While an avian
version of H7N9 viruses, with avian PB2 in a human virus
backbone (avian PB2), is unable to replicate in HEK293T cells,
other H7N9 viruses that contain different PB2 adaptation
markers were able to replicate to various levels in both HEK293T
and A549 cells, with the 526R/627K version of the virus
replicating to the highest levels (Fig. 4b,c). In contrast to the
results obtained in MDCK, HEK293T and A549 cells, there is no
replication advantage in avian cells (DF-1) for viruses containing
either single or coupled 526R/627K PB2 mammalian adaptation
markers, with the 526R/627K genotype being inhibited (Fig. 4d).
To exclude the possibility of underestimation of the growth
of avian PB2 virus in the MDCK cell-based plaque assay, we also
tested the titres of avian PB2 and avian 526R PB2 viruses by
assessing the 50% egg infectious dose, with the results indicating
that the plaque assay reﬂects the trend of virus titres obtained in
the growth kinetics experiments. These results further conﬁrmed
that the PB2-526R substitution may enhance replication of H7N9
viruses in mammalian cells, but not in avian cells.
PB2-526R enhances H7N9 virus replication in mice. To further
examine the effect of PB2-526R on virus replication, RG versions
of H7N9 viruses representing the different PB2 genotypes iden-
tiﬁed in human isolates were tested in a mouse infection model.
We ﬁrst estimated the 50% mouse lethal dose (MLD50) of H7N9
viruses containing different genotypes of PB2. Our results showed
that inclusion of K526R, alone or coupled with 627K or 701N,
increased mortality in the infected mice (Fig. 5a). To conﬁrm that
the K526R substitution caused increased virus replication in vivo,
mice were infected with a sub-lethal (2.25 104 plaque-forming
units (PFU), based on pre-experimental data obtained using
either 627K or 701N PB2 genotype viruses) dose of one of the
different versions of H7N9 virus and were observed, and changes
in body weight recorded over the following 14 days. Viruses
carrying 526R or 627K substitutions caused moderate body
weight loss (Fig. 5b,d), while RG avian H7N9 viruses or viruses
with 701N alone did not cause any apparent loss of body weight
in infected mice, as compared with the phosphate-buffered saline
(PBS) control or avian-type PB2 virus-infected groups (Fig. 5c,d).
Consistent with the results of the RNP polymerase activity and
growth kinetics assays, the 526R/627K PB2 genotype virus caused
the greatest body weight loss in mice, which peaked at around
25% on day 8 post infection (Fig. 5b). To examine virus repli-
cation ability in mouse lung tissues, three mice from each of the
PB2-526R, 526R/627K, 627K, 526R/701N, 701N, avian-PB2,
avian-PB2-526R and pure avian H7N9 (avian RG) infection
groups were euthanized on day 3 post infection and lung tissues
collected for virus titration. Consistent with the body weight loss
result, viruses carrying 526R/627K replicated to the highest titres
in the lungs of mice, about 1.5 to 2 logs higher than that in the
lungs of mice infected with H7N9 virus carrying avian type PB2
and signiﬁcantly higher than virus with 627K alone (Fig. 5b,d).
While 701N PB2 virus caused no apparent body weight loss in
mice, it replicated to a reasonably high titre in the lungs of
infected mice and its replication ability was enhanced by the
addition of 526R (Fig. 5c). H7N9 viruses carrying 526R PB2 also
exhibited enhanced replication (about 10-fold) in the lung tissues
of infected mice (Fig. 5d). Comparison of virus titres from mice
infected with 526R/627K, 526R/701N or 526R viruses mirrored
the results of the RNP activity and growth kinetics analyses,
conﬁrming that 526R/627K provides the most optimal PB2
genotype for replication of H7N9 virus in mammalian cells.
These results conﬁrm that the PB2-526R adaptation optimizes the
in vivo replication ability of H7N9 viruses in mammalian host
species.
PB2-526R confers a growth advantage in H3N2 virus.
As described above, the H3N2 virus obtained K526R around 1970
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Figure 3 | Quantitative estimation of vRNA and mRNA levels in H7N9
virus-infected A549 cells. A549 cells were infected with H7N9 viruses
carrying different PB2 adaptation markers, as indicated, at an MOI of 1.
Uni-12, Uni-13 and oligo dT primers were used for reverse transcription of
vRNA, cRNA and mRNA, respectively. Levels of M1 (a) and NP (b) genes
were estimated by quantitative RT-PCR and normalized with the b-actin
gene. (c) Veriﬁcation of speciﬁcity of primers used for viral mRNA and
vRNA using oligo dT, or uni-12 or uni-13 primed cDNA from NP plasmid
transfection and viral particles, respectively, as described in the Methods.
The values displayed represent the mean copy number per 105 b-actin copy
number±s.d. from three separate experiments. Statistical signiﬁcance
was calculated by the t-test: ***Po0.001 and *Po0.05. h.p.i.: hours post
infection.
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and the PB2-526R genotype immediately became the dominant
circulating H3N2 in humans, persisting to the current day
(Fig. 1). We have shown that addition of 526R to the PB2 of
A/Hong Kong/1/1968 H3N2 virus enhances RNP polymerase
activity, while back-mutation of 526R to 526K in the PB2 of
A/Guangdong/ST798/2008 decreased RNP polymerase activity
(Fig. 2b,c). To test whether gaining 526R has provided an addi-
tional growth advantage to the H3N2 virus, we constructed RG
versions of the H3N2 virus and a variant with a 526K back-
mutation in the A/Guangdong/ST798/2008 backbone. We
adopted an assay that was previously used for measuring a minor
growth advantage of H3N2 virus, obtained through acquisition
of seven C-terminal amino acids in inﬂuenza non-structural
protein 1, around 1950 to measure the growth rate advantage
associated with 526R PB2 (ref. 36). Evenly mixed 526R and 526K
PB2 versions of H3N2 virus were used to infect MDCK and A549
cells and then passaged sequentially. Aliquots of virus were
collected from each passage and subjected to sequence analysis
of the PB2-526R/526K mixed populations. All four of the
independent experiments performed showed that 526R PB2
virus had completely outgrown 526K at the 4th passage in A549
cells (4/4), while only one showed no change to the mixed
populations in MDCK cells (3/4) (Fig. 6a,b). In contrast to the
effect on H3N2 virus, introduction of K526R into PR8 (H1N1)
virus compromised virus replication in a similar assay
(Supplementary Fig. 4), suggesting that the dual 526R/627K
adaptive strategy is RNP complex speciﬁc. This evidence supports
our observations from H7N9 and H5N1-Indonesia viruses and
indicates that the K526R substitution in the PB2 polymerase
subunit provides a growth advantage to H3N2 inﬂuenza A virus,
which may further enhance replication in humans.
PB2-526R optimizes interaction between PB2 and NEP.
The molecular mechanism underlying host adaptation of inﬂu-
enza A virus through PB2 mutation remains largely undescribed.
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Figure 4 | Growth kinetics of H7N9 viruses carrying different PB2 variants in mammalian and avian cells. Reverse genetic versions of H7N9 viruses
containing avian-PB2, avian-PB2-526R, PB2-526R/627K, PB2-627K, PB2-526R/701N or PB2-701N, along with the remaining seven gene segments of
A/Zhejiang/DTID-ZJU01/2013, were used to infect (a) MDCK cells at an MOI of 0.001 and (b) HEK293T cells and (c) A549 cells at an MOI of 0.01.
The cells were cultured at 37 C and supernatants collected at 24, 48 and 72 h post infection and subjected to plaque assays in MDCK cells to determine
virus titres. (d) A subset of reverse genetic versions of H7N9 viruses containing avian-PB2, avian-PB2-526R, PB2-526R/627K or PB2-627K or rescued
reverse genetic A/Chicken/Zhejiang/DTID-ZJU01/2013 (Avian RG), were used to infect DF-1 cells at an MOI of 0.01 and cells were then cultured at 39 C.
Supernatants were collected at 24, 48 and 72 h post infection and subjected to plaque assays in MDCK cells to determine virus titres. The values displayed
are the log10 means±s.d. from three separate experiments. Statistical signiﬁcance was analysed by one-way analysis of variance, corrected by the
Bonferroni post-test: ***Po0.001 and **Po0.01. PFU, plaque-forming units; h.p.i., hours post infection.
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The viral NEP has been suggested to be involved in inﬂuenza
virus host adaptation through its action as a regulator to switch
on inﬂuenza virus genome transcription and replication37,38.
Expression of NEP is regulated during virus replication, and
increased expression of NEP brought about through disruption of
splicing control is deleterious to virus replication37,39. We
conﬁrmed the interaction between PB2 and NEP in a co-
immunoprecipitation assay using NEP and different versions of
PB2 derived from H7N9 virus (Fig. 7a). To test the impact of co-
expression of NEP on RNP polymerase activity, we co-expressed
RNP containing various PB2 genotypes with increasing amounts
of H7N9 virus NEP in HEK293T cells. Our result showed that
increased levels of NEP exert an inhibitory effect and that this
effect is much more profound for RNP with avian type PB2, but
less so for RNP complexes containing PB2-526R, PB2-701N and
PB2-627K. It is notable that when 526R is coupled with 627K in
PB2, the resulting RNP complex is able to tolerate much higher
levels of NEP (Fig. 7b). A similar inhibitory effect on RNP
polymerase activity by avian type NEP has been observed for
H5N1 viruses37. No adaptive substitutions have been observed in
the NEP of H7N9 virus. Analysis of NEP expression in MDCK
and A549 cells infected with H7N9 viruses carrying various PB2
markers conﬁrmed that NEP is not expressed in the earliest hours
of infection and that PB-526R-bearing viruses express higher
levels of NEP than their counterparts that lack this substitution
(Fig. 7c). Since PB2 interacts with both NP and PB1, we examined
the PB2–NP interaction, and found that 526R enhances the
interaction between PB2 and NP in the context of the RNP
(Supplementary Fig. 5). While further studies are needed to reveal
the molecular details of how PB2 and NEP interact with each
other and host factors, it seems possible that the K526R-adaptive
substitution enhances the interaction between PB2, the other
RNP subunits and NEP during virus replication.
Discussion
Historically, very few inﬂuenza viruses have become established
in mammalian hosts, namely the H1N1, H2N2 and H3N2
subtypes. Host adaptation requires the virus to overcome
restriction barriers and replicate efﬁciently in a new host.
To overcome host barriers, viruses must gain speciﬁcity for
binding to cell receptors, adapt to use host machinery for genome
replication, transcription and protein synthesis in cells and evade
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Figure 5 | Infection and replication of H7N9 viruses with different PB2 genotypes in mice. (a) Groups of mice were infected with 25ml inoculums
containing 104, 105 or 106 PFU of reverse genetic versions of viruses, as speciﬁed. Mice were observed daily for changes in body weight for 14 days
(day 0 to day 14). Animals that lost 425% of their pre-infection weight were euthanized, in accordance with our institutional animal ethics guidelines.
The MLD50 values were calculated by the method described by Reed and Muench
56. To test virus replication in mice, groups of nine BALB/c mice were
each inoculated intranasally with 2.25 104 PFU (25ml) of H7N9 recombinant virus containing PB2-526R/627K, PB2-627K, PB2-526R/701N, PB2-701N,
avian-PB2, avian-PB2-526R or with a wholly reverse genetic version of avian H7N9 virus (avian RG). Results compare the mean percentage weight loss or
gain for groups of mice infected with 627K or 526R/627K viruses or administered PBS (control) (b), 701N or 526R/701N viruses or PBS control (c) and
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(A/Zhejiang/DTID-ZJU01/2013) were killed at 72 h post infection. Lung tissues were removed and homogenated for estimation of virus replication by
the plaque assay. The values displayed represent the log10 mean titres±s.d. Statistical signiﬁcance was calculated by one-way analysis of variance,
corrected by the Bonferroni post-test: **Po0.01 and *Po0.05. d.p.i., days post infection.
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restriction by elements of the host innate immune system during
virus infection. The inﬂuenza virus replication complex is
composed of three polymerase subunits (PB1, PB2 and PA) plus
NP. Characterization of host adaptation markers among human
isolates is important for recognizing potential for cross-species
transmission in avian inﬂuenza A viruses. Adaptation of avian
inﬂuenza A virus polymerases in mammals has been extensively
studied and the most well-characterized adaptation markers are
located in the PB2 polymerase subunit40. The PB2 E627K
substitution is recognized as a dominant adaptation marker in the
majority of human-adapted inﬂuenza A viruses, facilitating
replication in mammalian cells, however, the 590S/591R motif
was found to complement the function of 627K in the PB2 of
2009 H1N1 virus to allow replication in humans41. While the
627K marker and, to a lesser extent, the 701N substitution have
been described as being critical for replication of avian H5N1 and
H7N7 viruses in mammalian hosts3,9, no known PB2 adaptation
marker has previously been characterized in the majority (B80%)
of H5N1 human isolates from Indonesia17,42.
Human infections with H7N9 virus emerged in China in
March 2013 (refs 19,20,31). While efﬁcient human to human
transmission was not observed and a serological study found no
evidence of circulation of H7N9 virus in the general population43,
sporadic inter-human transmissions were observed and
laboratory transmission studies indicate that, unlike the
H5N1 virus, this virus may be able to be transmitted between
ferrets44–48. Genetic analysis showed that the H7N9 virus is
currently still of the avian genotype49. In addition to the Q226L
substitution in the HA, which may provide the virus with some
ability to bind to human type receptors26,27, what other distinct
properties has this virus gained to make it different from other
avian inﬂuenza viruses? This study found that isolates from
human H7N9 cases carried one or more adaptation markers in
the PB2 polymerase gene (Table 1). No similar association was
found among avian or environmental H7N9 isolates, suggesting
these adaptive changes occurred after virus replication in human
cells. A distinct substitution, K526R, was found among some of
the human isolates, in conjunction with 627K or 701N markers.
The K526R substitution has not been recognized as a mammalian
adaptation marker previously. However, sequence surveillance
found that while 526R is not commonly present in human H5N1
isolates from most countries, nearly 80% of isolates from H5N1
human cases identiﬁed in Indonesia contain this marker (Table 1).
It seems likely that different genetic lineages of avian inﬂuenza
viruses evolve by using different adaptive pathways to enable their
replication in humans. For example, the 2009 H1N1 virus adapted
by using a PB2 590S/591R motif that synergized with the function
of 627K to gain the ability to replicate in humans. A similar
adaptive strategy was found among H9N2 human isolates, with 7
out of 10 human isolates containing the 590S substitution (Table 1).
The 526R PB2 mutation is rarely found among avian isolates
and it was logical to presume that it may be an uncharacterized
marker for human adaptation. Importantly, we found that the
H3N2 virus has also gained the PB2-K526R substitution, in
addition to 627K; this occurred around 1970, based on available
sequence data, and this genotype has become prevalent in
humans since then (Table 1; Fig. 1). It may be speculated that the
introduction of an avian PB1 into the H2N2 virus in the 1968
reassortment event might have necessitated a requirement for
rebalancing of RNP ﬁtness in the H3N2 virus, with the
combination of 526R/627K providing optimal efﬁciency for
RNP polymerases during H3N2 virus infections in humans.
Indeed, our results showed that PB2-526R/627K elicits higher
RNP polymerase activity when combined with the PB1 from 1968
reassortant H3N2 virus than does PB2-627K (Supplementary
Fig. 2). Introduction of 526R or 526K substitutions into A/Hong
Kong/1/1968 (526K PB2) and A/Guangdong/ST798/2008 (526R
PB2) PB2 proteins led to enhanced and reduced RNP polymerase
activity, respectively, in minigenome assays (Fig. 2). Furthermore,
the A/Guangdong/ST798/2008 version of H3N2 virus carrying
526R PB2 completely outgrows the 526K variant after only four
passages in infected MDCK and A549 cells (Fig. 6). It remains to
be tested whether the frequently higher seasonal activity of H3N2
virus in humans, compared with H1N1, may be due to its more
optimal replication properties and if gaining K526R has
contributed to the ﬁtness of H3N2 virus. Avian H5N1 virus has
caused 4600 human infections in over a dozen countries since
1997, and various adaptation markers in PB2 were observed
among human isolates (Table 1). It was suggested that the effect
of 627K on H5N1 virus may be dependent on the virus lineage18.
Interestingly, PB2 carrying 526R, but not 627K, is commonly
found among H5N1 human isolates from Indonesia, which has
the highest number of human H5N1 cases and the highest
mortality rate to date. We showed that mutation of PB2-526R to
526K completely abolished polymerase activity for RNP
complexes derived from one of the human isolates, A/
Indonesia/5/2005 (Fig. 2d). Taken together, these results
support the notion that K526R is a new adaptation marker for
H7N9 and H5N1-(Indonesia) avian inﬂuenza A virus in humans
and also provides an extra advantage for H3N2 virus replication.
Protein structure data for the C-terminal domain of PB2,
which contains the 627 and 701 residues, suggests that either
627K or 701N may enhance PB2 exposure to allow better
interaction with elements of the host machinery such as
importins, which facilitate nuclear import during virus
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Figure 6 | Comparison of the growth rate of H3N2 A/Guangdong/
ST798/2008 strains carrying either 526R or 526K PB2 in mixed
cultures. (a) MDCK cells or (b) A549 cells were infected at an MOI of
0.001 with a mixture (1:1) of wild-type (WT) (PB2-526R) and variant
(PB2 R526K) A/Guangdong/ST798/2008 and sequentially passaged four
times. At each passage viral RNA was isolated from cell culture
supernatants at 48 h post infection, and the PB2 gene ampliﬁed by RT-PCR
and sequenced. The genetic code for WT PB2-526R is AGA; variant PB2
526K is AAA. The DNA sequence chromatograms shown are from one
of the three MDCK (a) and one of the four A549 (b) experiments in
which 526R outgrew 526K. Experiments were repeated four times.
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infection50,51. There is no structural data available for analysing
the domain that covers the region containing residue 526. How
this region may enhance the ﬁtness of PB2, or whether it interacts
with residues 627 and 701 or other polymerase subunits, remains
to be determined. Recent studies suggest that NEP has a role in
regulating inﬂuenza A virus genome transcription and replication,
independent to its nuclear export function37. This study provides
preliminary evidence that gaining the 526R substitution in the PB2,
in addition to other adaptation markers, could enhance RNP
polymerase activity through coordination with NEP expression for
more efﬁcient viral transcription and genome replication during
inﬂuenza A virus infection.
Further studies are necessary to determine whether viruses
that have gained dual 526R/627K or 526R/701N substitutions
may transmit more efﬁciently in humans, or in animal models.
Full evaluation of the transmission and replication abilities of
H7N9 and other avian inﬂuenza A viruses, such as H5N1-
(Indonesia), bearing K526R PB2 will provide valuable informa-
tion for understanding the adaptation process and establish the
importance of this new marker in surveillance of zoonotic
inﬂuenza A viruses.
Methods
Viruses. All inﬂuenza viruses used in this study were rescued using the RGs
technique to ensure the absence of contamination from other microbes. Viruses
were propagated in embryonated chicken eggs (9–11 days old) for 3 days (P1),
using the standard protocol approved by the Committee on the Use of Live
Animals in Teaching & Research (CULATR) of the University of Hong Kong.
Viral genome characterization and RGs. The H7N9 viruses from laboratory-
conﬁrmed human cases have been characterized in our previous studies20,52.
The sequences of strains of H7N9 and H3N2 viruses used in this study have been
deposited in Genbank (Accession codes AGU02226 to AGU02234, KJ633805, and
KJ473719 to KJ473726). Eight segments from the A/Zhejiang/DTID-ZJU01/2013
and A/Chicken/Zhejiang/DTID-ZJU01/2013 strains were cloned into a pHW2000
plasmid system33,53,54, to be used as backbones. RG versions of both A/Zhejiang/
DTID-ZJU01/2013 (human, ZJ/1, PB2-701N) and A/Chicken/Zhejiang/DTID-
ZJU01/2013 (avian RG) were constructed. The ZJ/1 backbone was used to rescue
recombinant viruses with various PB2 genes containing different adaptation
markers. Minigenomes from the H3N2 strains A/Hong Kong/1/68 and
A/Guangdong/ST798/2008, the H5N1 strain A/Indonesia/5/2005 and RG versions
of A/Guangdong/ST798/2008 were cloned similarly and used to rescue virus
together with 526K or 526R PB2 genes. Additional PB2 variants were generated
using the QuikChange mutagenesis kit (Agilent) and also rescued using the ZJ/1
backbone. Full-length PB2 sequences of human and avian H5N1, H9N2, H7N7 and
H7N9 viruses from the National Center for Biotechnology Information (NCBI)
Inﬂuenza Virus Resource Database, together with all inﬂuenza A H7N9 human
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Figure 7 | Effect of PB2-526R in interaction between PB2 and NEP. (a) Co-immunoprecipitation of NEP with different versions of PB2 polymerase derived
from H7N9 virus. Enhanced GFP (eGFP)-NEP and FLAG-PB2 were co-expressed in HEK293Tcells. Whole-cell extracts were used for immunoprecipitation
with an anti-GFP antibody and analysed by western blot analysis, using speciﬁc antibodies against eGFP and FLAG. The experiment was repeated three
times. (b) Effect of different levels of NEP on RNP polymerase activity. RNP complexes containing different versions of PB2 were co-transfected with
increasing amounts of NEP (H7N9) expression vector or empty vector, together with the ﬁreﬂy luciferase reporter pYH-Luci and a Renilla luciferase reporter
(internal control). Luciferase activity was measured at 24 h post transfection, following incubation at 37 C, and the effect of different amounts of NEP on
the polymerase activity of RNP with and without PB2-526R was compared. Data represent mean luciferase activity from three separate experiments,
calculated after normalization with Renilla luciferase activity,±s.d. ‘—’ represents blank control; RNP without the PB2 gene. Statistical signiﬁcance was
analysed by the Student’s t-test: ***Po0.001, **Po0.01. (c) Western blot analysis of NEP expression in MDCK and A549 cells infected with H7N9 viruses
carrying different versions of the PB2 segment. Conﬂuent MDCK or A549 cells were infected with various reverse genetic H7N9 viruses, at an MOI
of 1. Cells were collected at 5 and 7 h post infection and whole-cell lysates were analysed for NEP and NP expression by western blot using antibodies
speciﬁc for NEP and NP, respectively. Blotting with antibody against b-tubulin, which served as a loading control, was also performed. Numbers indicate
the ratio of NEP expression between viruses carrying 526R in the PB2 and those without 526R. The experiment was repeated twice. Full-size western
blots are provided in Supplementary Fig. 6.
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isolates in the Global Initiative on Sharing All Inﬂuenza Data (GISAID) database
(http://gisaid.org) were analysed for prevalence of the K526R substitution.
Minigenome reporter assays. Luciferase activity-based minigenome reporter
assays were performed as described previously53. RNP complexes composed of PA,
PB1, PB2 and NP derived from A/Zhejiang/DTID-ZJU01/2013 and cloned into
the pHW2000 vector (50 ng each) were mixed with a luciferase reporter plasmid
(50 ng) and a thymidine kinase promoter-Renilla luciferase reporter plasmid
(pRL_TK) construct (10 ng), then co-transfected into HEK293T cells and
incubated at 37 C or 33 C, supplied with CO2. For luciferase reporter assays in
DF-1 cells, a luciferase reporter containing a chicken RNA polymerase I (Pol I)-
driven promoter was constructed based on the sequence previously described55,
and the transfected DF-1 cells were incubated at 39 C. The luciferase activity was
measured using a Dual-Luciferase Reporter Assay System (Promega) at 24 h post
transfection. RNP polymerase activity was normalized against pRL_TK activity.
To test the effect of NEP on RNP activity, experiments were performed as
previously described37. The coding region of the RNP complex (PB1, PB2, PA and
NP) and NEP were cloned separately into the pCX plasmid. HEK293T cells were
transfected with the pCX-based RNP expression plasmids, the NEP expression
plasmid and the two luciferase reporter plasmids, and RNP activity measured
at 24 h post transfection.
Growth kinetics of virus in cells. Conﬂuent MDCK cells were infected with
RG viruses at a multiplicity of infection (MOI) of 0.001. The viral inoculums were
removed after 1 h of adsorption at 37 C and replaced with minimal essential media
(MEM) containing 1 mgml 1 of L-(tosylamido-2-phenyl) ethyl chloromethyl
ketone (TPCK)-treated trypsin. Infected cells were further incubated at 37 C,
supplied with 5% CO2. Culture supernatants were collected at different time points
post infection and viral titres determined by the plaque assay in MDCK cells.
Conﬂuent DF-1 cells were infected with RG viruses at an MOI of 0.01. The viral
inoculums were removed after 1 hours’ adsorption at 39 C, then cells were washed
with MEM and overlaid with MEM containing 0.5 mgml 1 of TPCK–trypsin.
Infected cells were further incubated at 39 C, supplied with 5% CO2. Culture
supernatants were collected at different time points post infection and viral titres
determined by the standard 50% tissue culture infective dose assay in MDCK cells.
Replication in mice and lethal dose determination. Female BALB/c mice,
aged 4–6 weeks, were obtained from the Laboratory Animal Unit, the University of
Hong Kong. For MLD50 determination, groups of four or six mice were anesthe-
tized with isoﬂurane (Halocarbon Laboratory), and intranasally inoculated
with 25 ml of 10-fold serial dilutions of RG virus in PBS, the dose range being
104–106 PFU. Body weight and survival were monitored daily for 14 days after
infection. The MLD50 of RG viruses were calculated by the method of Reed and
Muench56. To test virus replication in mice, groups of six or nine mice were
anesthetized with isoﬂurane, and inoculated intranasally with 2.25 104 PFU
(25 ml) of H7N9 RG viruses. Animals were observed daily for mortality and body
weight was measured for up to 14 days after infection. At 72 h post infection, three
mice from each of the groups infected with virus containing 526R/701N, 701N,
526R/627K or 627K PB2, avian-PB2, avian-PB2-526R or with RG avian H7N9
virus, or mock-infected with PBS were euthanized and lung tissues were collected
from each mouse for virus titration and histochemical staining. The protocols for
animal experiments and the use of embryonated chicken eggs (9–11 days old) were
approved by the CULATR, Li Ka Shing Faculty of Medicine, the University of
Hong Kong (CULATR 3064-13). The CULATR follows the Hong Kong legislation
and standards/guidelines recommended by the Association for Assessment and
Accreditation of Laboratory Animal Care International (http://www.aaalac.org/
about/guidelines.cfm).
Quantitative RT-PCR assays for vRNA and mRNA. To test the speciﬁcity of
the qPCR assay for viral mRNA, an NP-expressing plasmid was transfected into
HEK293T cells for 48 h. Total RNA was extracted using the RNAiso reagent
(Takara). Plasmid DNA present in the total RNA was eliminated by deoxyr-
ibonuclease (DNase) treatment (Ambion), in accordance with the user manual.
Puriﬁed viral particles were used to test the speciﬁcity of the qPCR assay for
vRNA. Total vRNA was again extracted using RNAiso. Complementary DNA
was synthesized using oligo dT, uni-12 or uni-13 primers, and the copy number
of NP was then quantiﬁed by qPCR using NP-speciﬁc primers.
To evaluate the levels of vRNA and mRNA in virus-infected cells, A549 cells
were infected with different H7N9 viruses at an MOI of 1. Total RNA was extracted
at selected time points. One microgram of total RNA was reverse transcribed using
a high-capacity cDNA synthesis kit (Invitrogen). For detection of vRNA and
mRNA, uni-12 primer and oligo dT primer, respectively, were used in the RT
reaction. Expression of these two RNA species of the NP and M1 genes was
quantiﬁed using SYBR Premix Ex Taq reagent (Takara) in an ABI 7500 real-time
PCR machine (Applied Biosystems Inc.). For the detection of the M1 gene, M1-72s
(50-cgcacagagacttgaggatg-30) and M1-270as (50-tgggtctccattcccattta-30) primers
were used. For the detection of NP, NP-545s (50-cagtgaaggggatagggaca-30) and
NP-746as (50-ccaggatttctgctctctcg-30) primers were used. b-actin expression was
detected for each sample and used for normalization of gene expression between
different samples. The ampliﬁcation programme was as follows: 95 C for 30 s,
followed by 40 cycles of 95 C for 5 s, 60 C for 30 s. The speciﬁcity of the assay was
conﬁrmed by melting-curve analysis at the end of the ampliﬁcation programme
(65 to 95 C, 0.1 C s 1) (ref. 57).
Sequential passage of mixtures of H3N2 PB2-526R and 526K. Mutation at the
PB2 526 position was performed using the QuikChange site-directed mutagenesis
kit (Agilent) and RG H3N2 wild-type and PB2 mutant viruses were rescued, as
previously described54. Passage of H3N2 A/Guangdong/ST798/2008 wild-type
virus (PB2-526R) and its mutant (PB2-526K) was carried out according to
established procedures36. MDCK and A549 cells were infected at an MOI of 0.001
with wild-type ST978 virus, the mutant virus or a 1:1 mixture of the two viruses.
Four serial passages were performed, each with an MOI of 0.001. vRNA was
isolated from cell culture supernatants at 48 h post infection, and the PB2 gene
ampliﬁed by RT-PCR and sequenced.
Immunoprecipitation assay. To study the interaction between NEP and PB2,
HEK293T cells were transfected with green ﬂuorescent protein (GFP)-tagged NEP
expression plasmid and FLAG-tagged PB2 expression plasmid. After 48 h, cells
were lysed in cell lysis buffer (Tris-HCl 50mM, 150mM NaCl, 1% TritonX,
pH 7.4). Cell debris was cleared by centrifugation, and 1 ml of GFP antibody
(Invitrogen) was added to the cell lysate, which was then incubated for 3 h at 4 C.
Thirty microliters of protein A sepharose beads (GE Health) were then added to
the lysate, followed by incubation for 1 h at 4 C. The beads were washed with cell
lysis buffer and ﬁnally boiled in SDS buffer at 95 C. Proteins were resolved with
SDS–polyacrylamide gel electrophoresis and detected by western blot using anti-
GFP (dilution 1:1,000) (Invitrogen), anti-FLAG (dilution 1:3,000) and anti-b-actin
(dilution 1:5,000) (Sigma) antibodies. To study the interaction between NP and
PB2 in RNP complexes, pCX plasmids expressing PB1, PA, NP and FLAG-tagged
PB2 were co-transfected into HEK293T cells. The immunoprecipitation steps were
performed as described above, except that a laboratory-made polyclonal NP
antibody (dilution 1:3,000) was used.
Statistical analysis. Statistical analysis was carried out using GraphPad Prism V5
software (GraphPad Software Inc.).
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